Latest Stories
Uncategorized
Anthropic Buys One-Person Biotech Mithril Medicine, Opens Claude-Run Drug Pipeline With Six Pharma Partners
Anthropic announced on October 27 that it acquired Mithril Medicine, a biotech founded and run by a single scientist, and disclosed six separate pharma collaborations as it moves from selling AI tools to running its own Claude-assisted drug programs.
Uncategorized
Suki Raises $90 Million Series E as Its AI Medical Scribe Hits 450 Health System Customers
Suki closed a $90 million Series E led by Healthier Capital, scaling its AI medical-scribe platform to roughly 450 customers and projecting as much as $80 million in 2026 revenue, as ambient-documentation tools become one of the most adopted categories in clinical AI.
Uncategorized
Aidoc Raises $150 Million Series E Led by Goldman Sachs to Scale Its Hospital Diagnostic AI
Aidoc closed a $150 million Series E led by Goldman Sachs Alternatives, pushing its total funding past $500 million as the hospital imaging-AI company pivots from single-disease alerts toward a broader clinical foundation model.
Uncategorized
AstraZeneca Pays Up to $1.5 Billion for insitro’s Machine-Learning Drug Target Platform
AstraZeneca is paying insitro up to $1.5 billion to use machine learning to find and validate new drug targets, the latest entry in a pharma AI dealmaking spree that topped $47 billion in licensing agreements in just the first half of 2026.
In-Depth
Uncategorized
Takeda Signs Up to $1.7 Billion AI Deal With Iambic Therapeutics for Small-Molecule Drug Design
Takeda signed a multi-year AI drug discovery collaboration with Iambic Therapeutics worth up to $1.7 billion in milestones, giving Takeda access to Iambic's NeuralPLexer protein-ligand prediction model for small-molecule programs in oncology and inflammatory disease.
Uncategorized
FDA Seeks Public Comment on Regulating Generative AI Medical Devices as Cleared AI Tools Top 700
The FDA's Digital Health Center of Excellence opened a public comment period, closing October 19, on a discussion paper proposing a risk-proportionate framework for regulating generative AI medical devices.
Uncategorized
GSK Widens AI Drug Design Deal With Chai Discovery After In-House Scientists Validate Its Models
GSK expanded its collaboration with Chai Discovery in October after its own scientists independently tested and validated the AI startup's molecular design models, a notable vote of confidence in Chai's approach.
Uncategorized
VA Awards Abridge a Multi-Year AI Scribe Contract Worth Up to $775.72 Million Across Vendors
The Department of Veterans Affairs has selected Abridge for an enterprise-wide ambient AI scribe contract with a five-year ceiling of $775.72 million across all eligible vendors, expanding a technology already deployed at roughly 70 VA medical centers.
Uncategorized
OpenAI Wires ChatGPT Into Epic’s Electronic Health Records in Push Toward Clinical Workflows
OpenAI announced on September 1 that ChatGPT for Healthcare now connects directly to Epic's electronic health record system, with UCSF Health piloting the read-only integration alongside a new plugin linking ChatGPT to nine public health databases.
